We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Effect of Ibuprofen on Serum Dapsone Levels and Disease Activity in Dermatitis Herpetiformis

Jeffrey B. Smith, MC; Jeffrey B. Fowler, MD; John J. Zone, MD
Arch Dermatol. 1994;130(2):257-259. doi:10.1001/archderm.1994.01690020127028.
Text Size: A A A
Published online


Dermatitis herpetiformis (DH) is an immunobullous disease characterized by deposition of IgA in dermal papillae.1 Factors known to exacerbate disease activity are gluten intake and topical and oral iodine.2,3 In 1985, Griffiths et al4 found that oral indomethacin also exacerbated this disease and, therefore, concluded that caution should be used with all nonsteroidal anti-inflammatory drugs (NSAIDs) in treating patients with DH.

We performed a double-blind, placebo-controlled, crossover study to determine if another NSAID, ibuprofen, had similar exacerbating effects on patients with DH.

Subjects and Methods.  We recruited 10 patients for our study (six men and four women) with biopsy-proven DH. Patients ranged in age from 33 to 78 years (mean age, 54.6±15.1 SD). No patient was taking any NSAID at the time of the study. Six of 10 patients were taking dapsone, one was receiving sulfapyridine, and three were not using any suppressive medication. Of these three


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.